Peripheral Vascular Devices Market By Product Type (Stents, Angioplasty Balloons, Peripheral Vascular Access Devices, Embolectomy Devices), By Application (Peripheral Artery Disease, Coronary Artery Disease, Aneurysm Treatment), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions), By Distribution Channel (Direct Sales, Distributors, Online Retailers), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Peripheral Vascular Devices Market was valued at USD 11.7 billion in 2024-e and will surpass USD 18.9 billion by 2030; growing at a CAGR of 8.3% during 2025 - 2030.

The peripheral vascular devices market is witnessing significant growth due to the rising prevalence of peripheral vascular diseases (PVD), coronary artery diseases, and aneurysms. These conditions are becoming more prevalent globally, particularly in aging populations and individuals with risk factors like diabetes, obesity, and hypertension. As healthcare systems continue to advance and improve, there is a growing demand for innovative and minimally invasive devices used in the treatment of these vascular conditions. Peripheral vascular devices, which include stents, angioplasty balloons, and embolectomy devices, are essential for enhancing blood flow, preventing vascular blockages, and treating peripheral artery disease (PAD) and other circulatory disorders.

The market's expansion is also fueled by the growing preference for less invasive surgical techniques, which result in shorter recovery times, fewer complications, and a reduction in overall treatment costs. Additionally, technological advancements in the design and functionality of these devices, such as the development of drug-eluting stents and high-quality angioplasty balloons, contribute to the improvement of patient outcomes. With increasing awareness, rising healthcare spending, and innovations in medical technology, the market for peripheral vascular devices is expected to continue to grow robustly in the coming years.

Stents Segment is Largest Product Type Owing to Efficacy in Treating Vascular Blockages

The stents segment holds the largest share in the peripheral vascular devices market, primarily due to their high effectiveness in treating vascular blockages and improving blood flow. Stents are commonly used to treat conditions like peripheral artery disease (PAD), coronary artery disease (CAD), and aneurysms. By keeping the blood vessels open, stents prevent the re-narrowing of arteries after procedures like angioplasty. The increased use of drug-eluting stents (DES), which release medication to reduce the risk of restenosis, has further propelled the demand for stents in vascular procedures.

Stents are used in various parts of the body, including coronary arteries, peripheral arteries, and renal arteries, making them versatile and applicable in a wide range of vascular conditions. As the global burden of cardiovascular diseases continues to rise, the demand for stents remains strong, positioning this product type as a market leader. The ongoing technological advancements in stent materials, design, and delivery mechanisms contribute to the segment’s growth and effectiveness in treating arterial blockages.

Peripheral Artery Disease Segment is Largest Application Segment Owing to High Prevalence

The peripheral artery disease (PAD) segment represents the largest application in the peripheral vascular devices market, owing to the high prevalence of PAD and the critical role of vascular devices in its management. PAD occurs when there is a buildup of fatty deposits in the peripheral arteries, often leading to restricted blood flow and severe complications, including limb amputation if left untreated. Vascular devices such as stents, angioplasty balloons, and peripheral vascular access devices are used to treat PAD and restore normal blood flow.

With an aging global population and the increasing incidence of risk factors such as smoking, diabetes, and high blood pressure, the prevalence of PAD is growing. These factors contribute to the expanding demand for peripheral vascular devices to effectively manage and treat PAD. Moreover, technological advancements in devices, such as self-expanding stents and improved balloon angioplasty systems, are further enhancing the treatment options available for PAD patients, making this application segment a major driver of market growth.

Hospitals & Clinics Segment is Largest End-User Owing to High Volume of Vascular Procedures

Hospitals and clinics are the largest end-users in the peripheral vascular devices market, accounting for the highest demand for these devices. The need for stents, angioplasty balloons, and embolectomy devices is most pronounced in hospitals and clinics where vascular procedures are performed on a large scale. These healthcare facilities have the necessary infrastructure, specialized staff, and technology to carry out complex vascular interventions, including the management of peripheral artery disease, coronary artery disease, and aneurysms.

Hospitals and clinics provide both emergency and elective care for patients suffering from vascular diseases, contributing to the significant demand for peripheral vascular devices. Additionally, these settings offer comprehensive patient monitoring, advanced diagnostic capabilities, and surgical expertise, all of which are essential for effective vascular treatments. As the prevalence of cardiovascular diseases rises, particularly among older populations, the demand for vascular procedures in hospitals and clinics is expected to remain robust, further solidifying this segment’s dominance.

Direct Sales Segment is Largest Distribution Channel Owing to Preference for Direct Transactions with Healthcare Providers

The direct sales segment dominates the peripheral vascular devices market, primarily due to the preference of healthcare providers for direct transactions with manufacturers and suppliers of vascular devices. Direct sales allow hospitals, clinics, and ambulatory surgical centers to maintain an efficient supply chain, ensuring timely access to necessary devices and minimizing disruptions in patient care. Additionally, manufacturers often provide additional support, training, and warranty services through direct sales channels, which further enhances the value for healthcare providers.

Direct sales are particularly common in markets with established healthcare systems, such as North America and Europe, where the volume of vascular procedures is high, and healthcare providers often prefer to work directly with manufacturers to ensure the quality and consistency of medical devices. Furthermore, direct sales enable manufacturers to build strong relationships with healthcare providers, ensuring the adoption and continued use of their products. This distribution channel is likely to remain a key driver of market growth as the demand for peripheral vascular devices continues to rise.

North America is Largest Region Owing to Advanced Healthcare Infrastructure and High Prevalence of Vascular Diseases

North America is the largest region in the peripheral vascular devices market, owing to the advanced healthcare infrastructure in the United States and Canada, coupled with the high prevalence of vascular diseases, particularly coronary artery disease and peripheral artery disease. The region's well-established healthcare system, which includes cutting-edge diagnostic technologies, skilled healthcare professionals, and state-of-the-art medical devices, contributes to the widespread adoption of peripheral vascular devices.

Furthermore, the high number of aging individuals in North America, along with increasing rates of risk factors such as obesity, diabetes, and hypertension, is driving the need for vascular interventions. The availability of advanced treatment options in North America, such as drug-eluting stents and minimally invasive angioplasty techniques, is further enhancing the demand for peripheral vascular devices. As the prevalence of vascular diseases continues to rise, North America will remain a dominant market, with ongoing technological advancements supporting continued growth.

Competitive Landscape

The peripheral vascular devices market is highly competitive, with several leading companies vying for market share through innovation, strategic partnerships, and acquisitions. Key players in the market focus on improving the design and functionality of vascular devices to offer enhanced performance, such as drug-eluting stents that minimize the risk of restenosis. Manufacturers are also investing in research and development to develop next-generation devices with superior materials, improved biocompatibility, and advanced delivery mechanisms.

Strategic collaborations between device manufacturers, healthcare providers, and research institutions are becoming more common as companies seek to expand their market presence and offer integrated solutions for vascular disease management. The competitive landscape is expected to remain dynamic, with companies continuing to develop and refine products to meet the growing demand for effective treatments in the peripheral vascular devices market.

List of Leading Companies:

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Johnson & Johnson
• Terumo Corporation
• Cordis Corporation
• Cook Medical
• Edwards Lifesciences
• Philips Healthcare
• Biotronik
• C.R. Bard (now part of BD)
• Avinger
• Gore Medical
• Teleflex
• Xtent, Inc.

Recent Developments:

• In December 2024, Medtronic launched a new peripheral artery stent designed for better flexibility and easier deployment.
• In November 2024, Abbott Laboratories introduced an advanced angioplasty balloon with enhanced performance for peripheral artery disease treatment.
• In October 2024, Boston Scientific announced the release of a new embolic protection device for use during peripheral vascular interventions.
• In September 2024, Johnson & Johnson expanded its peripheral vascular device line to include a new stent for treating larger arteries.
• In August 2024, Terumo Corporation received FDA approval for a new peripheral vascular access device to enhance patient comfort during procedures.

Report Scope: